Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Overcoming Fear of ‘CPV Monster,’ Drug Makers Launch Continued Process Verification Programs

This article was originally published in The Gold Sheet

Executive Summary

Most pharmaceutical manufacturers are adopting or making plans to adopt the continued process verification approach outlined in FDA’s November 2011 process validation guidance, which will shine a light on their manufacturing processes. But not everyone is anxious to see what that light will reveal.

You may also be interested in...



CPV Shines New Light on Old Manufacturing Processes

Biopharmaceutical manufacturers say that implementation of continued process verification has helped to update “archaic” manufacturing processes for legacy products and uncover problems with raw materials. They have reaped some business benefits as well.

FDA’s Quality Metrics Proposal Poses Challenges, Including Gaming, Cost

If it works, the quality metrics initiative outlined in draft FDA guidance will help the global pharmaceutical supply chain prevent quality failures and drug shortages. But there will be challenges.

FDA’s Quality Metrics Proposal Poses Challenges, Including 'Gaming,' Cost

If it works, tracking the four quality metrics outlined in FDA guidance will help the global pharmaceutical supply chain prevent quality failures and drug shortages.

Related Content

Topics

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel